HORIZON-EIC-2023-TRANSITIONCHALLENGES-01
HORIZON-EIC-2023-TRANSITIONCHALLENGES-01
Programme: Horizon Europe
12 projects · €29,441,377 total EU contribution (project-level) · 31 participating organizations · 10 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€29,441,377
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (9)
- Netherlands (6)
- Spain (5)
- France (3)
- DK (2)
- IL (2)
- BE (1)
- CH (1)
- FI (1)
- Italy (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- TECHNICAL UNIVERSITY OF DENMARK DTU2 projects · DK
- CSIC1 projects · ES
- ALU-FR1 projects · DE
- Annaida1 projects · CH
- BFORCURE1 projects · FR
- CHARLES RIVER NEDERLAND BV1 projects · NL
- CAU1 projects · DE
- DELBIOS PHARMACEUTICALS SL1 projects · ES
- DEMCON LIFE SCIENCES & HEALTH ENSCHEDE BV1 projects · NL
- DEMCON SYNC BIOSYSTEMS BV1 projects · NL
- ESQLABS GMBH1 projects · DE
- Fraunhofer1 projects · DE
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
DRUG-ELUTING ELECTRICAL IMPLANT TO REPAIR THE SPINAL CORD DREIMS · 101136411 | HORIZON | €2,494,543 | €748,750 | Details |
Rapid Affordable Microbiota Analysis at the point of Need RAMAN · 101159437 | HORIZON | €2,466,224 | €2,466,224 | Details |
Preclinical development of a nanomedicine candidate for Fabry rare disease treatment to enter clinical phase Nano4Rare · 101136772 | HORIZON | €2,498,564 | €2,498,564 | Details |
Early detection of treatment response in breast cancer RESPONSE · 101158869 | HORIZON | €2,499,230 | €751,286 | Details |
PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cells Penphomet · 101158879 | HORIZON | €2,497,711 | €317,500 | Details |
Leveraging CRISPR-Cas for fast and accurate point-of-care diagnostics SCOPE · 101158803 | HORIZON | €2,498,125 | €2,498,125 | Details |
Dypha: adding the dimension of time to cell culture Dypha · 101158943 | HORIZON | €2,499,625 | €325,000 | Details |
Prefabricated Mature Blood Vessels and Tools for Vascularized 3D Cell Culture Vasc-on-Demand · 101156395 | HORIZON | €2,488,750 | €2,488,750 | Details |
Real time Liver disease early diagnosis through exhaled Volatile Organic Compounds sensing ReLiV · 101158688 | HORIZON | €2,499,875 | €2,499,875 | Details |
AUTOMATED CLINICAL PLATFORM FOR PERSONALIZED ANTIBIOTHERAPY IN CRITICAL UNITS BASED ON SURFACE ENHANCEMENT RAMAN SPECTROSCOPY ACU-SERS · 101158666 | HORIZON | €2,499,998 | €2,499,998 | Details |